Michael G. Mullen
Plus aucun poste en cours
Profil
Michael G.
Mullen served as Chairman of Kiora Pharmaceuticals, Inc. and Director of Oldtech, Inc. and Innoviva, Inc. He was also a Director at Bellevue Research, Inc. from 1999 to 2005 and an Analyst at Cowen & Co. LLC in 2001.
Prior to that, he was a Principal at Bellevue Group AG.
Mullen received his undergraduate degree from Fordham University and his MBA from Indiana University.
Anciens postes connus de Michael G. Mullen
| Sociétés | Poste | Fin |
|---|---|---|
Bellevue Research, Inc.
 Bellevue Research, Inc. Investment ManagersFinance Founded in 1998, Bellevue Research, Inc. is a fundamental equity investment research firm located in Boston. The firm is US investment research arm of Bellevue Asset Management AG, a privately-owned asset management group based in Zurich, Switzerland. Their ultimate parent is Bellevue Group AG. Bellevue research provides research to Bellevue Asset Management with coverage of the biotechnology, genetic engineering and pharmaceuticals sectors. | President | - |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Analyst-Equity | 16/11/2001 |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Directeur/Membre du Conseil | - |
| INNOVIVA, INC. | Directeur/Membre du Conseil | - |
| BELLEVUE GROUP AG | Directeur/Membre du Conseil | 18/02/2011 |
Formation de Michael G. Mullen
| Fordham University | Undergraduate Degree |
| Indiana University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| INNOVIVA, INC. | Health Technology |
| BELLEVUE GROUP AG | Finance |
| Entreprise privées | 3 |
|---|---|
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Finance |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Health Technology |
Bellevue Research, Inc.
Bellevue Research, Inc. Investment ManagersFinance Founded in 1998, Bellevue Research, Inc. is a fundamental equity investment research firm located in Boston. The firm is US investment research arm of Bellevue Asset Management AG, a privately-owned asset management group based in Zurich, Switzerland. Their ultimate parent is Bellevue Group AG. Bellevue research provides research to Bellevue Asset Management with coverage of the biotechnology, genetic engineering and pharmaceuticals sectors. | Finance |
